Login
$PHOE
$15.30 +$0.30 (2.0%) Close

Consolidated Balance Sheets

In USD, except per-share amounts
Q4 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Mar 31, 2025
Assets
Current assets
Cash at banks
Accounts receivable, net
Contract assets, net
Deferred offering cost
Deposits
Deposits and prepayments
Total current assets
Non-current assets
Plant and equipment, net
Right-of-use assets - operating lease
Contract assets, net
Prepayments
Deferred tax assets
Total non-current assets
Total assets
Liabilities
Current liabilities
Accounts payable
Finance lease liabilities
Operating lease liabilities
Due to a director
Director
Total due to a director
Accrued expenses
Income tax payable
Total current liabilities
Non-current liabilities
Operating lease liabilities
Finance lease liabilities
Long service payments obligation
Total non-current liabilities
Total liabilities
Shareholders’ equity
Ordinary shares, 5,000,000,000 shares authorized; USD0.00001 par value, 21,600,000 and 20,000,000 shares issued and outstanding, as of March 31, 2026 and 2025, respectively
Additional paid in capital
Retained earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support